These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 22956445)

  • 1. Lichen sclerosus in a breast cancer survivor on an aromatase inhibitor: a case report.
    Potter JE; Moore KA
    J Gen Intern Med; 2013 Apr; 28(4):592-5. PubMed ID: 22956445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lichen sclerosus in breast cancer survivor.
    Vieira-Baptista P
    J Gen Intern Med; 2013 Mar; 28(3):344. PubMed ID: 23299266
    [No Abstract]   [Full Text] [Related]  

  • 3. Lichen sclerosus in a breast cancer survivor.
    Moore KA; Potter JE
    J Gen Intern Med; 2013 Mar; 28(3):345. PubMed ID: 23288380
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug-induced pruritic micropapular eruption: anastrozole, a commonly used aromatase inhibitor.
    Bremec T; Demsar J; Luzar B; Pavlović MD
    Dermatol Online J; 2009 Jul; 15(7):14. PubMed ID: 19903442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anastrozole-induced hepatotoxicity.
    Zapata E; Zubiaurre L; Bujanda L; Piérola A
    Eur J Gastroenterol Hepatol; 2006 Nov; 18(11):1233-4. PubMed ID: 17033446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in endocrine therapy: anastrozole and advanced breast cancer in postmenopausal women.
    Nabholtz JM
    Am J Hosp Palliat Care; 2004; 21(6):457-65. PubMed ID: 15612238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extended adjuvant therapy with anastrozole among postmenopausal breast cancer patients: results from the randomized Austrian Breast and Colorectal Cancer Study Group Trial 6a.
    Jakesz R; Greil R; Gnant M; Schmid M; Kwasny W; Kubista E; Mlineritsch B; Tausch C; Stierer M; Hofbauer F; Renner K; Dadak C; Rücklinger E; Samonigg H;
    J Natl Cancer Inst; 2007 Dec; 99(24):1845-53. PubMed ID: 18073378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anastrozole.
    Cuzick J
    Drugs Today (Barc); 2005 Apr; 41(4):227-39. PubMed ID: 16034487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of adjuvant exemestane versus anastrozole on bone mineral density for women with early breast cancer (MA.27B): a companion analysis of a randomised controlled trial.
    Goss PE; Hershman DL; Cheung AM; Ingle JN; Khosla S; Stearns V; Chalchal H; Rowland K; Muss HB; Linden HM; Scher J; Pritchard KI; Elliott CR; Badovinac-Crnjevic T; St Louis J; Chapman JA; Shepherd LE
    Lancet Oncol; 2014 Apr; 15(4):474-82. PubMed ID: 24636210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is long-term adjuvant treatment of breast cancer with anastrozole indicated?
    Doggrell SA
    Expert Opin Pharmacother; 2008 Jun; 9(9):1619-22. PubMed ID: 18518790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anastrozole for breast cancer: recent advances and ongoing challenges.
    Buzdar AU
    Expert Rev Anticancer Ther; 2006 Jun; 6(6):839-48. PubMed ID: 16761927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anastrozole-related acute hepatitis with autoimmune features: a case report.
    Inno A; Basso M; Vecchio FM; Marsico VA; Cerchiaro E; D'Argento E; Bagalà C; Barone C
    BMC Gastroenterol; 2011 Mar; 11():32. PubMed ID: 21453541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lichen sclerosus involving the vagina.
    Longinotti M; Schieffer YM; Kaufman RH
    Obstet Gynecol; 2005 Nov; 106(5 Pt 2):1217-9. PubMed ID: 16260578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extended adjuvant therapy for breast cancer--how much is enough?
    Prowell TM; Stearns V
    J Natl Cancer Inst; 2007 Dec; 99(24):1825-7. PubMed ID: 18073372
    [No Abstract]   [Full Text] [Related]  

  • 15. Aromatase inhibitor-associated arthralgias: Pathogenesis, frequency and management.
    Altundag K; Dede D; Harputluoglu H; Gullu I
    Joint Bone Spine; 2007 Dec; 74(6):662-3. PubMed ID: 17913550
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of anastrozole across the breast cancer continuum: from advanced to early disease and prevention.
    Nabholtz JM
    Oncology; 2006; 70(1):1-12. PubMed ID: 16439860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should aromatase inhibitors replace tamoxifen?
    Drug Ther Bull; 2003 Aug; 41(8):57-9. PubMed ID: 12966738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Intensification of a diffuse chronic pain syndrome by the introduction of an aromatase inhibitor].
    Nemitz N; Kurmann PT; Van Linthoudt D
    Praxis (Bern 1994); 2008 Feb; 97(3):137-41. PubMed ID: 18549014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anastrozole versus tamoxifen in postmenopausal women with ductal carcinoma in situ undergoing lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial.
    Margolese RG; Cecchini RS; Julian TB; Ganz PA; Costantino JP; Vallow LA; Albain KS; Whitworth PW; Cianfrocca ME; Brufsky AM; Gross HM; Soori GS; Hopkins JO; Fehrenbacher L; Sturtz K; Wozniak TF; Seay TE; Mamounas EP; Wolmark N
    Lancet; 2016 Feb; 387(10021):849-56. PubMed ID: 26686957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extended adjuvant aromatase inhibition after sequential endocrine therapy (DATA): a randomised, phase 3 trial.
    Tjan-Heijnen VCG; van Hellemond IEG; Peer PGM; Swinkels ACP; Smorenburg CH; van der Sangen MJC; Kroep JR; De Graaf H; Honkoop AH; Erdkamp FLG; van den Berkmortel FWPJ; de Boer M; de Roos WK; Linn SC; Imholz ALT; Seynaeve CM;
    Lancet Oncol; 2017 Nov; 18(11):1502-1511. PubMed ID: 29031778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.